Ireland - English - HPRA (Health Products Regulatory Authority)

covidien (uk) commerical limited - ioversol - solution for inj/inf - 350

Ireland - English - HPRA (Health Products Regulatory Authority)

covidien (uk) commerical limited - ioversol - solution for injection - 350

Australia - English - Department of Health (Therapeutic Goods Administration)

mallinckrodt australia pty ltd - ioversol -

Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - iodixanol -

New Zealand - English - Medsafe (Medicines Safety Authority)

ge healthcare limited t/a ge healthcare - medical diagnostics - iodixanol 305 mg/ml equivalent to 150 mg/ml iodine - solution for injection - 150 mg/ml - active: iodixanol 305 mg/ml equivalent to 150 mg/ml iodine excipient: calcium chloride dihydrate hydrochloric acid sodium calcium edetate sodium chloride trometamol water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

ge healthcare limited - iodixanol 550 mg/ml equivalent to 270 mg/ml iodine - solution for injection - 270 mg/ml - active: iodixanol 550 mg/ml equivalent to 270 mg/ml iodine excipient: calcium chloride dihydrate hydrochloric acid sodium calcium edetate sodium chloride trometamol water for injection - this medicine is for diagnostic use only. visipaque is indicated, in adult patients, for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct-enhancement and studies of the upper gastrointestinal tract.

New Zealand - English - Medsafe (Medicines Safety Authority)

ge healthcare limited - iodixanol 652 mg/ml equivalent to 320 mg/ml iodine - solution for injection - 320 mg/ml - active: iodixanol 652 mg/ml equivalent to 320 mg/ml iodine excipient: calcium chloride dihydrate hydrochloric acid sodium calcium edetate sodium chloride trometamol water for injection - this medicine is for diagnostic use only. visipaque is indicated, in adult patients, for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct-enhancement and studies of the upper gastrointestinal tract.

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as acetate - powder and solvent for suspension for injection - triptorelin as acetate 3.75 mg/vial - triptorelin - triptorelin - lowering sexual hormones, prostate cancer, endomedtriosis, uterus myomatosus, fertility treatment ivf. central precocious puberty.

Ireland - English - HPRA (Health Products Regulatory Authority)

covidien (uk) commerical limited - ioversol - solution for inj/inf - 160 micromol

Canada - English - Health Canada

ge healthcare canada inc - iodixanol - solution - 550mg - iodixanol 550mg - roentgenography